Breakfast seminar
Tuesday, December 6 | 8:00 - 9:00 a.m. EST
Convention Center, Gran Cancun 5

Extraordinary science: harnessing novel workflows in the pursuit of advancing life science research


The evolution of mass spectrometry and rapid enhancements in accurate mass technology have allowed the life sciences field to accomplish remarkable research and enable new workflows previously never thought possible.  

Join us for breakfast on Tuesday, December 6th at the 2022 HUPO World Congress to learn about exciting innovations in proteomics. Our esteemed panel of guest speakers will share their latest work and how novel workflows enabled by SCIEX technologies are being used in fields like single cell, biomarker discovery, immunopeptidomics, and high throughput proteomics!

  • Learn about novel innovations in accurate mass analysis delivering both speed and accuracy for large-scale proteomics
  • Hear about the development of a standardized platform for robust, in-depth high-throughput proteome analysis
  • Discover the impact of sensitivity gains on the identification and quantification of proteins and peptides


Featured panelists:


Benjamin C. Orsburn, PhD
Principal Investigator, Johns Hopkins School of Medicine

Professor Anthony Purcell, PhD
Dept. of Biochemistry and Molecular Biology, Monash University

Hugo Gagnon, PhD
Chief Scientific Officer, PhenoSwitch Bioscience and Allumiqs

Dorte Bekker Jensen, PhD
Senior Scientist, Evosep

Register now

Booth #310

December 5-7, 2022
Cancun International Convention Center

After 2 years of HUPO’s virtual events, we cannot wait to see you in person at one of the largest international gatherings in the field of proteomics.

Visit our booth to learn more about the #Zenorevolution and the latest technologies from SCIEX.

The Zeno revolution brings a whole new level of proteomic depth that can be discovered by uncovering unique fragmentation patterns and low abundant species. As leaders in the quantification of molecules, we understand the importance of precision and accurate mass in furthering our understanding of disease mechanisms and biological diversity to offer clinical solutions.